caa a22 4500 445332204 CHVBK 20180317142741.0 cr unu---uuuuu 170323e20111201xx s 000 0 eng 10.1007/s10198-010-0271-1 doi (NATIONALLICENCE)springer-10.1007/s10198-010-0271-1 The impact of repeated cost containment policies on pharmaceutical expenditure: experience in Spain [Elektronische Daten] [Iván Moreno-Torres, Jaume Puig-Junoy, Josep Raya] The growth in expenditure on the financing of pharmaceuticals is a factor that accounts for a large part of the increase in public health spending in most developed countries. In an attempt to kerb this growth, many health authorities, particularly in Europe, have introduced numerous regulatory measures that have affected the market, especially on the supply side. These measures include the system of reference pricing, the reduction of wholesale distributors' and retailers' markups and compulsory reductions of ex-factory prices. We assess the impact of these cost containment measures on expenditure per capita, prescriptions per capita and the average price of pharmaceuticals financed by the public sector in Catalonia (Spain), from 1995 to 2006. We apply an autoregressive integrated moving average (ARIMA) time series model using dummy variables to represent the various cost containment measures implemented. Twelve of the 16 interventions analysed that were intended to contain the overall pharmaceutical expenditure were not effective in reducing it even in the short term, and the four that were effective were not so in the long term, thus amounting to a moderate annual saving. Springer-Verlag, 2010 Pharmaceutical expenditure nationallicence Pharmaceutical policy nationallicence Cost containment measures nationallicence Time series nationallicence Moreno-Torres Iván Research Centre for Economics and Health (CRES), Department of Economics and Business, Universitat Pompeu Fabra, Ramon Trias Fargas 25-27, 34-08005, Barcelona, Spain aut Puig-Junoy Jaume Research Centre for Economics and Health (CRES), Department of Economics and Business, Universitat Pompeu Fabra, Ramon Trias Fargas 25-27, 34-08005, Barcelona, Spain aut Raya Josep Department of Economics and Business and Escola Universitària del Maresme (EUM), Universitat Pompeu Fabra, Ramon Trias Fargas 25-27, 34-08005, Barcelona, Spain aut The European Journal of Health Economics Springer-Verlag 12/6(2011-12-01), 563-573 1618-7598 12:6<563 2011 12 10198 https://doi.org/10.1007/s10198-010-0271-1 text/html Onlinezugriff via DOI 1 research-article jats NATIONALLICENCE 856 40 https://doi.org/10.1007/s10198-010-0271-1 text/html Onlinezugriff via DOI NATIONALLICENCE 700 1- Moreno-Torres Iván Research Centre for Economics and Health (CRES), Department of Economics and Business, Universitat Pompeu Fabra, Ramon Trias Fargas 25-27, 34-08005, Barcelona, Spain aut NATIONALLICENCE 700 1- Puig-Junoy Jaume Research Centre for Economics and Health (CRES), Department of Economics and Business, Universitat Pompeu Fabra, Ramon Trias Fargas 25-27, 34-08005, Barcelona, Spain aut NATIONALLICENCE 700 1- Raya Josep Department of Economics and Business and Escola Universitària del Maresme (EUM), Universitat Pompeu Fabra, Ramon Trias Fargas 25-27, 34-08005, Barcelona, Spain aut NATIONALLICENCE 773 0- The European Journal of Health Economics Springer-Verlag 12/6(2011-12-01), 563-573 1618-7598 12:6<563 2011 12 10198 Metadata rights reserved Springer special CC-BY-NC licence nationallicence BK010053 XK010053 XK010000 NATIONALLICENCE NATIONALLICENCE NL-springer